Recombinant Human Erythropoietin Dramatically Reduces Blood Transfusion Rate in Long-Term Acute Care Patients
New findings suggest that administering recombinant human erythropoietin to patients admitted to a long-term acute care facility significantly reduces their need for allogeneic blood, investigators
